New frontiers in CNS
- Session 1: From target selection to small molecules design
Marco de Vivo (IIT)
Maria Laura Bolognesi (University of Bologna)
Stephen Penrose (Anima Biotech)
This first session will cover CNS challenges in drug discovery, showcasing medicinal and computational chemistry case studies, across a range of modalities and target classes, as well as covering more general topics of relevance to scientists. Focus will be on overcoming the most common issues when dealing with CNS drug design, and exploration of innovative and advanced scientific achievements in the treatment of neurological disorders.
Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Torre R, 4a planta, Despatx A05, Parc Científic de Barcelona (PCB). C/ Baldiri Reixac 4-8 08028 Barcelona